Growth Metrics

Eledon Pharmaceuticals (ELDN) Profit After Tax Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 65.80%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.05%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -290.15%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 59.59%
7 Evaxion A 62.56 Bn 62.54 Bn - -129.68%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,228.66%
10 Eledon Pharmaceuticals 419.90 Mn 203.87 Mn - -500.85%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -500.85%
Dec 31, 2025 76.65%
Sep 30, 2025 -122.68%
Jun 30, 2025 75.02%
Mar 31, 2025 72.51%
Dec 31, 2024 -48.23%
Sep 30, 2024 877.01%
Jun 30, 2024 31.71%
Mar 31, 2024 -119.37%
Dec 31, 2023 48.45%
Sep 30, 2023 5.40%
Jun 30, 2023 -611.15%
Mar 31, 2023 -9.21%
Dec 31, 2022 -563.00%
Sep 30, 2022 -6.66%
Jun 30, 2022 -25.23%
Mar 31, 2022 -16.06%
Dec 31, 2021 -49.15%
Sep 30, 2021 -59.78%
Jun 30, 2021 -185.54%
Mar 31, 2021 -3.94%
Dec 31, 2020 -42.47%
Sep 30, 2020 -112.37%
Jun 30, 2020 36.82%
Mar 31, 2020 -67.53%
Dec 31, 2019 9.40%
Sep 30, 2019 17.25%
Jun 30, 2019 -28.35%
Mar 31, 2019 -73.95%
Dec 31, 2018 -116.78%
Sep 30, 2018 -17.71%
Jun 30, 2018 52.13%
Mar 31, 2018 -104.22%
Dec 31, 2017 43.54%
Sep 30, 2017 -45.95%
Jun 30, 2017 -564.87%
Mar 31, 2017 87.97%
Dec 31, 2016 66.08%
Sep 30, 2016 82.83%
Jun 30, 2016 88.81%
Mar 31, 2016 13.83%
Dec 31, 2015 -77.46%
Sep 30, 2015 -85.49%
Jun 30, 2015 -53.08%
Mar 31, 2015 -173.57%
Dec 31, 2014 -12.36%
Sep 30, 2014 -89.90%